4BTU
Factor Xa in complex with the dual thrombin-FXa inhibitor 57.
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | ESRF BEAMLINE ID23-2 |
| Synchrotron site | ESRF |
| Beamline | ID23-2 |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2007-04-18 |
| Detector | MARRESEARCH |
| Spacegroup name | P 32 |
| Unit cell lengths | 55.760, 55.760, 173.140 |
| Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
| Resolution | 46.510 - 2.370 |
| R-factor | 0.17284 |
| Rwork | 0.169 |
| R-free | 0.24761 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | IN-HOUSE FACTOR XA STRUCTURE |
| RMSD bond length | 0.005 |
| RMSD bond angle | 0.968 |
| Refinement software | REFMAC (5.7.0029) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 55.760 | 2.450 |
| High resolution limit [Å] | 2.370 | 2.370 |
| Rmerge | 0.090 | 0.410 |
| Number of reflections | 24437 | |
| <I/σ(I)> | 9.4 | 2.8 |
| Completeness [%] | 100.0 | 100 |
| Redundancy | 3.2 | 3.1 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, HANGING DROP | 5.7 | PROTEIN SOLUTION: 8 MG/ML REMARK 280 DESGLA FACTOR XA, 5 MM MES (PH 6.0), 5 MM CACL2, 100 MM REMARK 280 BENZAMIDINE. RESERVOIR SOLUTION: 18-20% PEG600, 50 MM MES REMARK 280 (PH 5.7). HANGING DROP SETUP. |






